Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein for SLN mapping in melanoma
NCT00847522Phase 2Completed
- Sponsor
- University of Utah
- Start
- Feb 2009
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorescein sodium 10% injection in melanoma, sponsored by University of Utah. Started Feb 2009; status: completed.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00847522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847522.